Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Applied Genetic Tech (AGTC)

Applied Genetic Tech (AGTC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 112,258
  • Shares Outstanding, K 25,866
  • Annual Sales, $ 2,450 K
  • Annual Income, $ -45,890 K
  • 60-Month Beta 2.62
  • Price/Sales 45.34
  • Price/Cash Flow N/A
  • Price/Book 1.98
Trade AGTC with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.59
  • Number of Estimates 3
  • High Estimate -0.59
  • Low Estimate -0.60
  • Prior Year -0.47
  • Growth Rate Est. (year over year) -25.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.88 +11.86%
on 11/20/20
5.76 -24.65%
on 11/10/20
-0.99 (-18.57%)
since 10/27/20
3-Month
3.88 +11.86%
on 11/20/20
6.47 -32.96%
on 09/03/20
-0.69 (-13.72%)
since 08/27/20
52-Week
2.29 +89.52%
on 03/18/20
10.42 -58.35%
on 01/22/20
+1.54 (+55.00%)
since 11/27/19

Most Recent Stories

More News
Applied Genetic Technologies (AGTC) Reports Q1 Loss, Misses Revenue Estimates

Applied Genetic Technologies (AGTC) delivered earnings and revenue surprises of -17.65% and -100.00%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for...

AGTC : 4.34 (+0.93%)
Applied Genetic Technologies: Fiscal 1Q Earnings Snapshot

ALACHUA, Fla. (AP) _ Applied Genetic Technologies Corp. (AGTC) on Monday reported a loss of $15.4 million in its fiscal first quarter.

AGTC : 4.34 (+0.93%)
AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2020

Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases,...

AGTC : 4.34 (+0.93%)
After Yesterday's Decline of 8.14%, Applied Genetic Offers Investors Better Value

Applied Genetic (NASDAQ:AGTC) traded in a range yesterday that spanned from a low of $5.07 to a high of $5.35. Yesterday, the shares fell 8.1%, which took the trading range below the 3-day low of $5.21...

AGTC : 4.34 (+0.93%)
AGTC to Host Conference Call on November 11 at 8:00 am ET to Discuss XLRP 12-Month Data and Full 6-Month Data from Highest Dose Groups of its Ongoing Phase 1/2 Clinical Trial

Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases,...

AGTC : 4.34 (+0.93%)
American Gilsonite to Post 3rd Quarter 2020 Financial Results and Announces Conference Call Details

, /PRNewswire/ -- American Gilsonite Company (the "Company" or "AGC"), the world's principal commercial miner and processor of uintaite, the unique mineral marketed under its trademark name "Gilsonite,"...

AGTC : 4.34 (+0.93%)
AGTC to Participate in Cantor Fitzgerald Virtual Panel: Key Considerations for Gene Therapy Manufacturing and Platforms

Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company focused on developing adeno-associated virus (AAV) based gene therapies for the treatment of rare inherited diseases, today...

AGTC : 4.34 (+0.93%)
AGTC to Present at Upcoming Virtual Conferences

Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company focused on developing adeno-associated virus (AAV) based gene therapies for the treatment of rare inherited diseases, today...

AGTC : 4.34 (+0.93%)
Applied Genetic Shares Up 55.0% Since SmarTrend's Buy Recommendation (AGTC)

SmarTrend identified an Uptrend for Applied Genetic (NASDAQ:AGTC) on March 24th, 2020 at $3.29. In approximately 6 months, Applied Genetic has returned 55.02% as of today's recent price of $5.10.

AGTC : 4.34 (+0.93%)
Applied Genetic Technologies: Fiscal 4Q Earnings Snapshot

ALACHUA, Fla. (AP) _ Applied Genetic Technologies Corp. (AGTC) on Wednesday reported a loss of $14.5 million in its fiscal fourth quarter.

AGTC : 4.34 (+0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops gene therapy products for inherited orphan ophthalmology diseases. Its lead product candidates in the preclinical stage include treatments for X-linked retinoschisis, Achromatopsia, and X-linked retinitis...

See More

Key Turning Points

2nd Resistance Point 4.44
1st Resistance Point 4.39
Last Price 4.34
1st Support Level 4.28
2nd Support Level 4.22

See More

52-Week High 10.42
Fibonacci 61.8% 7.31
Fibonacci 50% 6.36
Fibonacci 38.2% 5.40
Last Price 4.34
52-Week Low 2.29

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar